Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIsara Phiwchaien_US
dc.contributor.authorWiphawee Yuensooken_US
dc.contributor.authorNatsaree Sawaengsiriphonen_US
dc.contributor.authorSaowalak Krungchanuchaten_US
dc.contributor.authorChalermchai Pilapongen_US
dc.description.abstract© 2017 Elsevier B.V. This report presents the potential utilization of tannic acid (TA) as a natural iron chelator. TA is capable of binding with small ferric complexes without competitive binding with endogenous iron-containing molecules such as ferritin and transferrin. It was observed that the extracellular iron binding of TA resulted in the formation of self-assembled Fe3 +-TA complexes, which were then taken up by HepG2 cells via phagocytosis pathway with autophagy-inducing properties. Obviously, TA was found to inhibit iron-induced HepG2 cell growth. However, cellular interactions and biological responses to the treatment were found to depend on availability of iron. Based on the results of the iron efflux experiment, it can be stated that TA has the capability to mobilize iron from cells in the form of assembled Fe3 +-TA complexes. Interestingly, TA-mediated cellular iron influx and efflux were successfully monitored via MRI. The results of this study suggest that TA can be used as a molecular tool for chelating and imaging labile iron. This might be a promising approach for prevention and treatment of iron-associated cancer or other iron overload disorders.en_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTannic acid (TA): A molecular tool for chelating and imaging labile ironen_US
article.title.sourcetitleEuropean Journal of Pharmaceutical Sciencesen_US
article.volume114en_US Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.